The waitlist has become a standard feature of AI product launches, ostensibly to manage capacity during a controlled rollout. In practice, waitlists frequently persist well past the point where genuine capacity constraints would justify them, functioning more as a marketing device manufacturing a sense of scarcity and demand than as an honest reflection of rollout limitations.
Why waitlists are an effective marketing tool
A product that's hard to access generates more curiosity and social proof - people talking about wanting access - than one immediately available to everyone. This dynamic is well understood in product marketing generally and applies just as effectively to AI launches, independent of whether a real capacity constraint exists.
How to tell a genuine constraint from a marketing device
A genuine capacity-driven waitlist typically shows steady, transparent movement, with the company communicating realistic timelines and reasons for delay. A marketing-driven waitlist tends to move unpredictably, favor high-visibility or well-connected requesters, and persist without clear communication about what's actually being managed.
Why this distinction matters for coverage
A story describing overwhelming demand for a new AI product, evidenced primarily by waitlist length, is repeating a metric the company fully controls and has strong incentive to make appear as large and urgent as possible. Waitlist size alone is a weak, easily-manufactured signal of genuine demand.
What a more skeptical read looks like
Asking how many people have actually been granted access, on what cadence, and why - rather than reporting waitlist size as a demand signal on its own - gives a more accurate picture of whether a launch reflects genuine capacity management or a manufactured sense of exclusivity.